Home / Therapies / Blood Glucose Control (page 19)

Blood Glucose Control

15-Minute Nutrition Counseling for Diabetes: Scripts and Tools That Work

A female doctor provides diabetes nutrition counseling to a patient using a plate method diagram in a clinical setting.

In a typical primary care or endocrinology visit, time is a precious resource. And while most clinicians understand the importance of diabetes nutrition counseling, it can be hard to know what to say—or how to say it—in just a few minutes. This article equips healthcare providers with brief, evidence-based scripts …

Read More »

Hybrid Closed‑Loop Insulin Systems in Type 2 Diabetes: Who Should Use Them?

Hybrid closed-loop insulin system tools including insulin pump, CGM, and glucose meter used for managing type 2 diabetes.

As diabetes technology advances, hybrid closed‑loop systems are no longer exclusive to type 1 diabetes. In recent years, their use in insulin-treated type 2 diabetes has gained attention. These systems promise better glucose control and improved quality of life by automating much of the insulin delivery process. But are they …

Read More »

Type 2 Diabetes Drug Sequencing: A Step-by-Step Treatment Guide

Close-up of type 2 diabetes treatment planning with medication bottles, glucose-lowering drugs, and a clinical flowchart for drug sequencing

Treating type 2 diabetes is no longer a one-size-fits-all endeavor. As new therapies emerge, clinicians face the ongoing challenge of selecting and sequencing medications in a way that balances efficacy, safety, cost, and patient preference. This comprehensive guide to type 2 diabetes drug sequencing outlines practical strategies for initiating, intensifying, …

Read More »

Diabetes Management in Older Adults: Applying 2025 Guidance on Frailty and De‑Intensification

An older African American man consults with a female doctor about diabetes care, surrounded by a clipboard, glucometer, and medication.

Managing diabetes in older adults isn’t just about adjusting medications—it’s about seeing the full picture of aging, frailty, and functionality. New 2025 standards highlight the need to assess frailty and functional status when setting A1C goals in elderly patients. But how do clinicians know when it’s time to de-intensify therapy …

Read More »

Preventing DKA and HHS in Outpatient Settings: 2025 Updates Every Clinician Should Apply

Doctor discussing DKA outpatient prevention with a patient; ketone meter, insulin, glucose monitor, and a sick-day plan shown in foreground

Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are still two of the most dangerous acute complications facing people with diabetes. However, a large portion of these cases can be prevented outside of the hospital. In 2025, the American Diabetes Association (ADA) released expanded guidance focused on DKA outpatient prevention, …

Read More »

Perioperative GLP‑1 Management: What Every Diabetes Team Needs to Know

Perioperative checklist with GLP‑1 medication, syringe, and stethoscope in a hospital surgery setting, highlighting GLP‑1 perioperative management.

GLP‑1 receptor agonists and dual agonists like tirzepatide have become indispensable in managing type 2 diabetes and obesity. However, their effect on gastric emptying introduces specific risks during surgery that can’t be ignored. As their use grows, the need for clear, coordinated GLP‑1 perioperative management is more important than ever. …

Read More »

Sleep and Diabetes: Why the 2025 Guidelines Say It’s Time to Prioritize Rest

Woman peacefully sleeping in bed with a glucose meter, insulin vial, and digital clock on bedside table, representing sleep and diabetes connection.

Sleep and diabetes are more connected than ever before. According to the newly released 2025 guidelines, sleep has officially joined nutrition and exercise as a core pillar of cardiometabolic health. Why? Because science shows that poor sleep isn’t just tiring — it can directly impact blood sugar levels, insulin resistance, …

Read More »

Safe Use of Diabetes Technology: Reducing Device-Related Risks Without Losing the Benefits

A collection of diabetes technology devices including a CGM, insulin pump, glucose meter, and insulin pen, illustrating safe use strategies.

Diabetes technology safety has become a critical focus as continuous glucose monitors (CGMs), insulin pumps, and automated insulin delivery systems transform diabetes care. These tools improve glycemic outcomes, enhance quality of life, and support proactive management. However, with increased device complexity comes a unique set of risks clinicians must recognize …

Read More »

From A1C to TIR – Rethinking Glycemic Targets for Better Long‑Term Outcomes

A glucose meter reading 117 mg/dL placed over lab results showing Hemoglobin A1c and a Time in Range (TIR) chart with green, yellow, and red bars.

For decades, clinicians have relied on A1C as the primary benchmark for diabetes control. Yet many patients and providers now wonder: does a single quarterly number truly reflect daily glucose fluctuations and risks? As continuous glucose monitoring (CGM) becomes more accessible, the metric known as Time in Range (TIR) has …

Read More »